Purpose/objectives: To determine the effectiveness of a nurse-managed minimal smoking-cessation intervention among hospitalized patients with cancer.
Design: Prospective, two-group, randomized clinical trial.
Setting: Urban, academic, tertiary-care setting.
Sample: 28 adult male and female smokers with a diagnosis of cancer who are hospitalized for a surgical procedure.
Methods: During hospitalization, subjects were assigned to a minimal smoking-cessation intervention group (n = 14) or a usual care group (n = 14). Verification of smoking status was performed at a clinic visit six weeks postintervention. Nonsmoking status was defined as self-report of zero cigarettes/day during the prior week and confirmed by saliva cotinine analysis.
Main Research Variables: One-time, Inpatient, nurse-managed, minimal smoking-cessation intervention, self-reported smoking status, and saliva cotinine level of < or = 14 ng/ml.
Findings: Upon hospital admission, 64% of the intervention group and 71% of the usual care group reported their intention to quit smoking. At six weeks postintervention, only 21% and 14% of the intervention and usual care group, respectively, were classified as abstinent from smoking. More than 90% of the intervention group members who resumed smoking did so within first week of discharge.
Implications For Nursing Practice: A more intensive intervention may be necessary to assist hospitalized surgical patients in achieving smoking cessation. Additional contact prior to discharge or within the first few days postdischarge may be necessary to reinforce strategies for remaining abstinent.
Download full-text PDF |
Source |
---|
BMC Psychiatry
January 2025
Department of Behavioural Science and Health, University College London, London, 1-19 Torrington Place, WC1E 7HB, UK.
Background: Smoking rates in the UK have declined steadily over the past decades, masking considerable inequalities, as little change has been observed among people with a mental health condition. This trial sought to assess the feasibility and acceptability of supplying an electronic cigarette (e-cigarette) starter kit for smoking cessation as an adjunct to usual care for smoking cessation, to smokers with a mental health condition treated in the community, to inform a future effectiveness trial.
Methods: This randomised controlled feasibility trial, conducted March-December 2022, compared the intervention (e-cigarette starter kit with a corresponding information leaflet and demonstration with Very Brief Advice) with a 'usual care' control at 1-month follow-up.
BMC Complement Med Ther
December 2024
College of Medicine, University of Florida, Gainesville, FL, USA.
Background: As the primary cause of various preventable illnesses, smoking results in approximately five million premature deaths each year in the US and a multitude of adults living with serious illness. The majority of smokers know the health risks associated with smoking and intend to quit. However, quitting is very difficult partly because of insomnia and stress associated with it.
View Article and Find Full Text PDFJ Med Internet Res
December 2024
Institute for Global Tobacco Control, Department of Health, Behavior and Society, Johns Hopkins University, Baltimore, MD, United States.
In 2019, we launched a web-based longitudinal survey of adults who frequently use e-cigarettes, called the Vaping and Patterns of E-cigarette Use Research (VAPER) Study. The initial attempt to collect survey data failed due to fraudulent survey submissions, likely submitted by survey bots and other survey takers. This paper chronicles the journey from that setback to the successful completion of 5 waves of data collection.
View Article and Find Full Text PDFDrug Alcohol Depend
January 2025
Center of Excellence for the Acceleration of Harm Reduction, University of Catania, Italy; Department of Clinical and Experimental Medicine, University of Catania, Italy; Centre for the Prevention and Treatment of Tobacco Addiction (CPCT), University Teaching Hospital "Policlinico-S.Marco, " University of Catania, Italy.
Introduction: This umbrella review identified the current high-quality systematic reviews on e-cigarettes as a smoking cessation aid. What is the comparative effectiveness of e-cigarettes compared to other cessation treatments or approaches? We also investigated the systematic reviews for reporting biases.
Methods: This umbrella review was based on the Methods for Overviews of Reviews (MOoR) framework and the Preferred Reporting Items for Overviews of Reviews (PRIOR).
F1000Res
December 2024
Global Health and Population, Harvard T H Chan School of Public Health, Boston, Massachusetts, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!